(UL) Unilever - Ratings and Ratios
Shampoo, Soap, Detergent, Mayo, Ice-Cream
Description: UL Unilever
Unilever PLC (NYSE: UL) is a global fast-moving consumer goods (FMCG) company headquartered in London, operating across four continents and organized into five business segments: Beauty & Wellbeing, Personal Care, Home Care, Foods, and Ice Cream.
The Beauty & Wellbeing segment sells hair-care (shampoo, conditioner, styling), skin-care (moisturizers) and prestige beauty products; Personal Care covers soaps, showers, deodorants and oral-care items; Home Care includes fabric-care detergents, rinse conditioners and household cleaning solutions; Foods provides cooking aids, soups, seasonings, condiments and food-service solutions; and Ice Cream offers both in-home and out-of-home frozen desserts.
Key brands span the portfolio, from Axe, Dove, and Sunsilk to Knorr, Hellmann’s, Ben & Jerry’s, Magnum and Wall’s, giving Unilever a broad consumer reach and strong shelf presence in both emerging and developed markets.
Recent performance indicators (FY 2023) show underlying sales growth of roughly 5 % year-over-year, driven largely by price-adjustments that offset inflationary cost pressures, and an adjusted operating margin of about 15 %, reflecting continued efficiency gains in supply-chain automation.
Sector-wide drivers that materially affect Unilever include persistent global consumer-price inflation, which pressures discretionary spend on premium categories, and the accelerating shift toward e-commerce and direct-to-consumer channels that is reshaping distribution economics for FMCG firms.
Unilever’s strategic focus on sustainable sourcing (aiming for 100 % renewable electricity in its operations by 2030) and product-level environmental claims is increasingly tied to investor sentiment and regulatory risk, making ESG metrics a material component of its valuation.
For a deeper, data-driven valuation framework, the ValueRay platform offers granular, real-time metrics that can complement your analysis.
UL Stock Overview
| Market Cap in USD | 148,167m |
| Sub-Industry | Personal Care Products |
| IPO / Inception | 1988-01-04 |
UL Stock Ratings
| Growth Rating | 66.7% |
| Fundamental | 79.0% |
| Dividend Rating | 37.1% |
| Return 12m vs S&P 500 | -10.2% |
| Analyst Rating | 4.0 of 5 |
UL Dividends
| Dividend Yield 12m | 3.13% |
| Yield on Cost 5y | 3.82% |
| Annual Growth 5y | 0.23% |
| Payout Consistency | 91.8% |
| Payout Ratio | 88.2% |
UL Growth Ratios
| Growth Correlation 3m | 0.3% |
| Growth Correlation 12m | 61.7% |
| Growth Correlation 5y | 51.9% |
| CAGR 5y | 16.40% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.03 |
| CAGR/Mean DD 3y (Pain Ratio) | 2.89 |
| Sharpe Ratio 12m | -0.44 |
| Alpha | -4.07 |
| Beta | 0.247 |
| Volatility | 16.43% |
| Current Volume | 3772.9k |
| Average Volume 20d | 2471.2k |
| Stop Loss | 61.2 (-3%) |
| Signal | 0.94 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (12.20b TTM) > 0 and > 6% of Revenue (6% = 7.20b TTM) |
| FCFTA 0.19 (>2.0%) and ΔFCFTA 5.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.92% (prev -6.18%; Δ 1.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.24 (>3.0%) and CFO 17.87b > Net Income 12.20b (YES >=105%, WARN >=100%) |
| Net Debt (28.91b) to EBITDA (24.51b) ratio: 1.18 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.45b) change vs 12m ago -3.02% (target <= -2.0% for YES) |
| Gross Margin 43.51% (prev 23.98%; Δ 19.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 158.7% (prev 120.5%; Δ 38.27pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 41.87 (EBITDA TTM 24.51b / Interest Expense TTM 518.7m) >= 6 (WARN >= 3) |
Altman Z'' -0.72
| (A) -0.08 = (Total Current Assets 19.19b - Total Current Liabilities 25.10b) / Total Assets 76.00b |
| (B) -0.46 = Retained Earnings (Balance) -35.14b / Total Assets 76.00b |
| (C) 0.29 = EBIT TTM 21.72b / Avg Total Assets 75.63b |
| (D) -0.60 = Book Value of Equity -35.05b / Total Liabilities 58.20b |
| Total Rating: -0.72 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.01
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 9.20% = 4.60 |
| 3. FCF Margin 12.05% = 3.01 |
| 4. Debt/Equity 1.80 = 1.06 |
| 5. Debt/Ebitda 1.18 = 1.50 |
| 6. ROIC - WACC (= 43.27)% = 12.50 |
| 7. RoE 64.03% = 2.50 |
| 8. Rev. Trend 22.92% = 1.72 |
| 9. EPS Trend -17.68% = -0.88 |
What is the price of UL shares?
Over the past week, the price has changed by +4.45%, over one month by +1.12%, over three months by +6.46% and over the past year by +3.76%.
Is Unilever a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UL is around 64.05 USD . This means that UL is currently overvalued and has a potential downside of 1.47%.
Is UL a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the UL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 70 | 10.9% |
| Analysts Target Price | 70 | 10.9% |
| ValueRay Target Price | 69.7 | 10.4% |
Last update: 2025-10-13 02:04
UL Fundamental Data Overview
P/E Trailing = 23.2423
P/E Forward = 15.1976
P/S = 2.4789
P/B = 6.9204
P/EG = 1.67
Beta = 0.247
Revenue TTM = 120.06b EUR
EBIT TTM = 21.72b EUR
EBITDA TTM = 24.51b EUR
Long Term Debt = 24.87b EUR (from longTermDebt, last quarter)
Short Term Debt = 7.16b EUR (from shortTermDebt, last quarter)
Debt = 32.02b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 28.91b EUR (from netDebt column, last quarter)
Enterprise Value = 157.33b EUR (126.53b + Debt 32.02b - CCE 1.23b)
Interest Coverage Ratio = 41.87 (Ebit TTM 21.72b / Interest Expense TTM 518.7m)
FCF Yield = 9.20% (FCF TTM 14.47b / Enterprise Value 157.33b)
FCF Margin = 12.05% (FCF TTM 14.47b / Revenue TTM 120.06b)
Net Margin = 10.16% (Net Income TTM 12.20b / Revenue TTM 120.06b)
Gross Margin = 43.51% ((Revenue TTM 120.06b - Cost of Revenue TTM 67.82b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev -12.64%)
Tobins Q-Ratio = 2.07 (Enterprise Value 157.33b / Total Assets 76.00b)
Interest Expense / Debt = 1.62% (Interest Expense 518.7m / Debt 32.02b)
Taxrate = 25.17% (1.28b / 5.09b)
NOPAT = 16.25b (EBIT 21.72b * (1 - 25.17%))
Current Ratio = 0.76 (Total Current Assets 19.19b / Total Current Liabilities 25.10b)
Debt / Equity = 1.80 (Debt 32.02b / totalStockholderEquity, last quarter 17.79b)
Debt / EBITDA = 1.18 (Net Debt 28.91b / EBITDA 24.51b)
Debt / FCF = 2.00 (Net Debt 28.91b / FCF TTM 14.47b)
Total Stockholder Equity = 19.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.05% (Net Income 12.20b / Total Assets 76.00b)
RoE = 64.03% (Net Income TTM 12.20b / Total Stockholder Equity 19.05b)
RoCE = 49.46% (EBIT 21.72b / Capital Employed (Equity 19.05b + L.T.Debt 24.87b))
RoIC = 49.04% (NOPAT 16.25b / Invested Capital 33.14b)
WACC = 5.78% (E(126.53b)/V(158.56b) * Re(6.93%) + D(32.02b)/V(158.56b) * Rd(1.62%) * (1-Tc(0.25)))
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.52%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈12.77b ; Y1≈15.76b ; Y5≈26.88b
Fair Price DCF = 186.5 (DCF Value 457.22b / Shares Outstanding 2.45b; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -17.68 | EPS CAGR: -71.15% | SUE: 0.0 | # QB: 0
Revenue Correlation: 22.92 | Revenue CAGR: 5.02% | SUE: N/A | # QB: 0
Additional Sources for UL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle